InvestorsHub Logo
Followers 65
Posts 4647
Boards Moderated 0
Alias Born 02/12/2013

Re: None

Tuesday, 12/08/2020 2:28:53 PM

Tuesday, December 08, 2020 2:28:53 PM

Post# of 8
Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients

@LaughinPaulRyan - WSJ, High Times, Main Street, Yahoo!



Offering EXTREMELY valuable info and speculation without Explanation.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PEN News